Evidence map›Paper›PMID 42750421›Full record

ArticleRapid communications in mass spectrometry : RCM2026

On Serine Octamer Substitution Reactions.

Brison A Shira, Alana K E Thomas, R Graham Cooks

Abstract read
In one paragraph

Article in Rapid communications in mass spectrometry : RCM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brison A ShiraDepartment of Chemistry, Purdue University, West Lafayette, Indiana, USA.ORCID https://orcid.org/0000-0002-5250-5882
Alana K E ThomasDepartment of Chemistry, Purdue University, West Lafayette, Indiana, USA.
R Graham CooksDepartment of Chemistry, Purdue University, West Lafayette, Indiana, USA.ORCID https://orcid.org/0000-0002-9581-9603

Funding

Agilent TechnologiesMultidisciplinary University Research Initiative 62741613-204669Multidisciplinary University Research Initiative FA9550-21-1-0170
6 · The paper itself

Abstract

rationaleMonomeric amino acids substitute into the ionized serine octamer (Ser

methodsThe substitution reactions of several proteogenic AA's (Ala, Leu, isoLeu, Pro, Phe, and Val), along with prebiotically relevant isomers (norVal and isoVal), were investigated using a quadrupole ion trap mass spectrometer to gain insight into the determinants of the chiral behavior. Rather than using isotopically labeled enantiomers, as in previous work, cluster formation was assessed using samples of variable chiral composition and concentration.

resultsSubstitution enantioselectivity was confirmed, though in the case of some double substitutions and the substitution of nonproteogenic isomers, the homochiral preference was decreased or inverted, an observation which is attributed to the disruption of the highly ordered noncovalent contacts of the parent Ser

conclusionsThis investigation illustrates how chiral chemistry using MS must operate through weak but chirality-sensitive forces while avoiding dominance of stronger but chirality-insensitive reaction drivers; namely the propensity of a chiral organic base to acquire the charge of a proton affiliated with other chiral molecules. These results are significant because chiral molecular clusters are fundamentally interesting. Understanding the origins of their enantioselectivity contributes to a general understanding of how small molecules may recognize chirality in reaction partners and accumulate enantiomeric excess.

Indexed as

SerineAmino AcidsMass SpectrometryStereoisomerismAmino AcidsSerinechiral analysision trap mass spectrometrymolecular clustersserine octamer

Identifiers

PMID42750421
PMCPMC13583542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.